drugdeliverybusiness1 天
Beta Bionics goes public with upsized $204M IPO
Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering ...
drugdeliverybusiness9 天
Dexcom CEO says 2025 is ‘shaping up to be a good year’ with Stelo launch, GenAI integration
The Stelo glucose monitor for people with diabetes who are not taking insulin. [Image courtesy of Dexcom] After a busy 2024, Dexcom (Nasdaq:DXCM) Chair and CEO Kevin Sayer believes the company is set ...
drugdeliverybusiness1 天
Beta Bionics to raise $114.4M in IPO
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).
drugdeliverybusiness10 天
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump ...
The FreeStyle Libre 3 reader with the sensor and smartphone. [Image courtesy of Abbott] Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter ...